157 related articles for article (PubMed ID: 37820091)
1. Management of neurofibromatosis type 1 associated tumors of central and peripheral nervous system.
Eoli M
Curr Opin Oncol; 2023 Nov; 35(6):558-563. PubMed ID: 37820091
[TBL] [Abstract][Full Text] [Related]
2. Neurological malignancies in neurofibromatosis type 1.
Eoli M; Saletti V; Finocchiaro G
Curr Opin Oncol; 2019 Nov; 31(6):554-561. PubMed ID: 31436563
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
Longo JF; Weber SM; Turner-Ivey BP; Carroll SL
Adv Anat Pathol; 2018 Sep; 25(5):353-368. PubMed ID: 29762158
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G
J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in neurofibromatosis type 1.
Arun D; Gutmann DH
Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
8. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
10. How does the Schwann cell lineage form tumors in NF1?
Carroll SL; Ratner N
Glia; 2008 Nov; 56(14):1590-1605. PubMed ID: 18803326
[TBL] [Abstract][Full Text] [Related]
11. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 (NF1) and associated tumors.
Rosenbaum T; Wimmer K
Klin Padiatr; 2014 Nov; 226(6-7):309-15. PubMed ID: 25062113
[TBL] [Abstract][Full Text] [Related]
14. Primary progressive multiple sclerosis and neurofibromatosis type 1.
Iwanowski P; Kowalska M; Prendecki M; Dorszewska J; Kozubski W; Rydzanicz M; Płoski R; Losy J
Mult Scler Relat Disord; 2019 Jul; 32():66-69. PubMed ID: 31048186
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis.
McClatchey AI
Annu Rev Pathol; 2007; 2():191-216. PubMed ID: 18039098
[TBL] [Abstract][Full Text] [Related]
18. The Neurofibromatoses. Part 1: NF1.
Lu-Emerson C; Plotkin SR
Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
[TBL] [Abstract][Full Text] [Related]
19. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
Brossier NM; Carroll SL
Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
[TBL] [Abstract][Full Text] [Related]
20. An update on the central nervous system manifestations of neurofibromatosis type 1.
Nix JS; Blakeley J; Rodriguez FJ
Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]